Search

This study examined the effect of dietary lysolecithin on growth performance, nutrient digestibility, haematobiochemistry, and oxidative status in finisher broiler chickens. In a completely randomized design (CRD), 300 21-day-old Chikun strain chicks were randomly allocated to 30 pens in which they were allotted to 5 dietary treatments as follows TI (0 g /100kg), T2 (100 g /100kg), T3 (200 g /100kg), T4 (300 g /100kg), T5 (400 g /100kg) of feed with 6 replicates pens of 10 during the finisher phase (28 days). Results showed that dietary supplementation with lysolecithin increased the final body weight (FBW) (quadratic P = 0.0178), body weight gain (BWG) (quadratic P = 0.0232), whilst it decreased the total feed intake (TFI) (linear P = 0.0104). Similarly, it linearly increased the retention of dry matter (P = 0.0324); crude protein (P = 0.0029), crude fibre (P = 0.0147), and crude fat (P = 0.0002). Furthermore, it increased the superoxide dismutase (linear P < 0.001), glutathione peroxidase (quadratic P < 0.001), glutathione (linear P < 0.001), whilst it decreased malondialdehyde (linear P = 0.003), without affecting (P > 0.05) the haematobiochemistry parameters. Therefore, dietary lysolecithin could be supplemented up to 400 g /100 kg without compromising performance, nutrient retention, haemato-biochemistry, and oxidative status in finisher broiler diets. [ABSTRACT FROM AUTHOR]

The present study aimed to investigate the ameliorative effects of lysolecithin on fish stearin oil, meanwhile comparing the application of two different forms (lysolecithin powder and lysolecithin oil) and three inclusion levels (0.25, 0.75, 1.25 g kg−1) in largemouth bass. The entire study consisted of a 28-day digestibility trial and a consequent 68-day feeding experiment. Eight iso-nitrogenous (∼ 500 g kg−1) and iso-energetic (∼ 22 MJ kg−1) diets with high lipid level (∼ 170 g kg−1) were formulated to contain the same level of two different types of lysolecithin, and namely WFO (130 g kg−1 winterized fish oil), FSO (130 g kg−1 fish stearin oil), LLP (FSO + 1 g kg−1 lysolecithin powder, purity 250 g kg−1), MLP (FSO + 3 g kg−1 lysolecithin powder), HLP (FSO + 5 g kg−1 lysolecithin powder), LLO (FSO + 0.625 g kg−1 lysolecithin oil, purity 400 g kg−1), MLO (FSO + 1.875 g kg−1 lysolecithin oil) and HLO (FSO + 3.125 g kg−1 lysolecithin oil), respectively. Largemouth bass fed FSO showed lower apparent digestibility coefficients (ADCs) of nutrients (total fat, crude protein, gross energy, total amino acid, total essential amino acid) than the WFO. Without considering the lysolecithin type, medium and high doses (0.75, 1.25 g kg−1) significantly increased ADCs of nutrients compared with the 0.25 g kg−1 supplementation level. Lysolecithin oil significantly increased ADCs of nutrients than the lysolecithin powder. Thus, lysolecithin oil was chosen for 68-day feeding trial, and results showed the highest FBW, FI, WGR and SGR were recorded in diet HLO, and significantly higher than the FSO, LLO and MLO. Diet MLO significantly decreased lipid and energy in whole-body and lipid retention compared with the FSO, LLO and HLO. In addition, activity and mRNA expression of adipose triglyceride lipase significantly increased, while glycerol-3-phosphate acyltransferase 4 decreased in diet HLO.

This study aimed at investigating the effect of hydrolyzed soya lecithin; also called lysolecithin or lysophosphatidylcholine, on growth performance, caecal microbiota and fat depots in pre‐breeding primiparous rabbits does. For this, 60 V‐Line primiparous rabbits does (5–6 months) were used in a 30‐day experiment. Does were allotted into three iso‐nitrogenous iso‐caloric dietary treatments (n = 20/group) as follows: (1) CON received 0% soya lecithin, (2) LECL group was fed a basal diet supplemented with 0.5% soya lecithin and (3) LECH group was fed a basal diet supplemented with 1% soya lecithin. Growth performance indices were measured, caecum samples were collected for measurement of specific bacteria via qPCR, and several fat depots including periovarian fat were sampled for adipocyte morphometry and fatty acid profiling. Statistical analysis was performed using GLM procedures of SAS v9.4. Soya lecithin increased feed intake (p < 0.05). The abundance of caecal Bifidobacteria species, Ruminococcus species and phylum Butryvibrio‐specific genes increased (p < 0.05) in rabbits receiving soya lecithin in their diet, soya lecithin increased the level of polyunsaturated fatty acids in subcutaneous and perirenal fat (p < 0.05) and increased the level of monounsaturated fatty acids in periovarian fat (p < 0.05); additionally, the adipocyte area increased in periovarian and perirenal fat (p < 0.05). In conclusion, soya lecithin at a dose of 0.5% increased feed intake and energy storage in adipocytes and improved the fatty acid profile of periovarian fat. [ABSTRACT FROM AUTHOR]

A double-blind, placebo-controlled, crossover trial was performed to analyze the effects of a small amount of lysolecithin and canola oil on blood glucose levels after consuming japonica rice. Overall, 17 Japanese adult men were assigned to consume 150 g of normally cooked japonica rice (placebo group) and 150 g of japonica rice cooked with 18 mg of lysolecithin and 1.8 g of canola oil (treatment group); these lipids were added as emulsified formulation (EMF) for stability and uniformity. Subsequently, blood samples were collected before and 30, 45, 60, 90, and 120 min after consuming test foods. There was no significant difference in blood glucose, insulin, and triglyceride levels between the groups. However, a stratified analysis of 11 subjects with body mass index (BMI) ≥ 22 revealed that blood glucose levels were significantly lower after 30 min in the treatment group than in the placebo group (p = 0.041). Through in vitro digestibility test, the rice sample of the treatment group was observed to release significantly less glucose within 20 min than that in the placebo group rice. These results suggest that the combination of a small amount of lysolecithin and canola oil modulated the increase in postprandial blood glucose levels induced by the intake of cooked japonica rice in adult men with BMI ≥ 22. This clinical trial was registered with the University Hospital Medical Information Network (UMIN) Center, (UMIN000045744; registered on 15/10/2021). [ABSTRACT FROM AUTHOR]

Simple Summary: Lysophospholipids (LPL) are monoacyl derivatives of phospholipids in which one of the fatty acids has been removed by enzymatic hydrolysis and can influence lipid digestion. In this study, the effect of feeding lysophospholipids in the diet to pigs from 7–30 kg was investigated with respect to growth performance and the intestinal morphology. A total of 800 pigs were divided into two groups fed either basal diet (CON) or basal diet + 0.05% LPL (LPL), respectively, and the growth performance was measured for 42 days. At the end of the experiment, 32 pigs were euthanized to evaluate the tissue of the small intestine in the pigs. Overall, there was no statistical difference between day 1 and day 42 relating to overall gain or growth performances. However, due to the variations between the two groups starting phases, the results indicate that lysophospholipids had a positive effect on recovering from a poorer starting point. This was further reinforced by intestinal morphology analysis, which also showed no statistical difference, despite the early lag in growth performance of the LPL group. Inclusion of lysophospholipids (LPL) has been proposed to increase growth performance in broilers and pigs, acting as emulsifiers through mixed micelle formation. The aim of this study was to investigate the effect of feeding LPL in weanling pig diets on growth performance and intestinal morphology. Eight hundred pigs (weight 6.96 kg ± SD 1.58 kg) were assigned to one of two dietary treatments, i.e., a basal diet (CON) or a basal diet + 0.05% lysophospholipids (LPL). The experimental period lasted for 42 days, and on days 40 and 41, 32 pigs in total were euthanized for intestinal tissue samples. From days 14 to 21, feed intake and average daily gain increased, as well as FCR, from days 28 to 42, in the LPL group compared with the CON group. In the overall period, no differences in growth performance were present between the groups. However, females displayed increased ADG from days 21 to 28 compared with castrates. The villous height tended (p = 0.051) to be lower in LPL in the proximal jejunum compared with CON. In the proximal jejunum, villus was higher (p > 0.01) in females, and in the distal jejunum, higher crypt cell proliferation (p < 0.01) and a tendency to deeper crypts (p = 0.064) were observed in female pigs as well. In conclusion, lysophospholipids did not increase growth performance in this study; however, the rate of recovery from a poorer starting point was noted, as growth rates recovered and increased faster in the LPL group. In conclusion, unlike the first phase, the LPL group recovered the growth from days 14 to 21 through higher feed intake and weight gain than the CON group. Eventually, the LPL group displayed improved FCR compared with the CON group from days 28 to 42. Further studies are needed to investigate whether this effect continues into the grower–finisher phase. [ABSTRACT FROM AUTHOR]

The hydrophilic–lipophilic balance (HLB) is a valuable parameter used to determine the relative hydrophobicity of a compound based on its chemical structure. This semi-empirical parameter has been instrumental in formulating oil-in-water and water-in-oil emulsions using well-characterized ingredients with known HLB values. However, recent trends toward the use of minimally processed "virgin" oils of therapeutic or nutritional value may render the reported "required HLB" values inaccurate. Minimally processed oils can contain numerous compounds at varying or unknown concentrations, rendering the HLB value incalculable. Factors such as regional source, growing season, and processing method contribute to the variability in oil composition. Furthermore, the solubilization of lipophilic bioactives in oils can significantly alter the HLB of the oil phase in a concentration-dependent manner. This complicates the formulation of emulsions, as the HLB values of both the oil phase and emulsifiers must be closely matched to achieve stable formulations. This study presents a simple and efficient experimental method to determine an HLB value of a complex ingredient without resorting to lengthy Design-of-Experiment (DoE) matrices and trial-and-error approaches. The optimal HLB of a formulation can be determined from a series of experiments in which two well-characterized surfactants of known HLB values are mixed at varying proportions with an unknown oil phase, where the HLB of the oil is considered to match the HLB value of the surfactants combined at the proportion at which nanoemulsions with the smallest, most stable oil droplets are formed. Similarly, when the HLB values of the oil phase and other contributing components are precisely known, the unknown HLB of a complex natural surfactant can be calculated. These calculations assist in formulating emulsions efficiently and effectively by ensuring optimal compatibility among all the components. [ABSTRACT FROM AUTHOR]

1. This study investigated the effects of lysolecithins (LL) on performance, egg quality, blood profiles, relative organ weight and liver histopathology in laying hens. 2. A total of 480 healthy 65-week-old Lohmann laying hens were randomly allocated into four treatments in a 2 × 2 factorial arrangement design with two levels of energy (AMEn, 11.08 MJ/kg and 12.94 MJ/kg) and two levels of LL (0 and 0.05%). 3. Birds fed high energy diets had lower (P < 0.05) average daily intake and feed conversion rate during weeks 0–4, 5-8 and 0–8, but higher (P < 0.05) average egg weight (AEW) during trial weeks 0–4. There was an interaction in (P < 0.05) AEW during trial weeks 0–14 and 0–8 for energy and LL. The high energy diets increased yolk colour at the end of weeks 2 and 4, while addition of LL increased albumen height at the end of week 2. There was an interaction (P < 0.05) in yolk colour between energy and LL at the end of week 2. There was an interaction (P < 0.05) in serum superoxide dismutase and LDL-C throughout the experiment. 4. The high energy diets increased (P < 0.05) the relative weight of abdominal fat compared with low energy diets. The high energy diets increased (P < 0.05) liver ether extract content and liver pathological injury score compared with low energy diets at the end of week 8, while the addition of LL decreased (P < 0.05) liver pathological injury score. 5. The supplementation of LL in high energy diets could alleviate some negative effects on liver injury in late laying hens. [ABSTRACT FROM AUTHOR]

Inclusion of lysophospholipids (LPL) has been proposed to increase growth performance in broilers and pigs, acting as emulsifiers through mixed micelle formation. The aim of this study was to investigate the effect of feeding LPL in weanling pig diets on growth performance and intestinal morphology. Eight hundred pigs (weight 6.96 kg ± SD 1.58 kg) were assigned to one of two dietary treatments, i.e., a basal diet (CON) or a basal diet + 0.05% lysophospholipids (LPL). The experimental period lasted for 42 days, and on days 40 and 41, 32 pigs in total were euthanized for intestinal tissue samples. From days 14 to 21, feed intake and average daily gain increased, as well as FCR, from days 28 to 42, in the LPL group compared with the CON group. In the overall period, no differences in growth performance were present between the groups. However, females displayed increased ADG from days 21 to 28 compared with castrates. The villous height tended (p = 0.051) to be lower in LPL in the proximal jejunum compared with CON. In the proximal jejunum, villus was higher (p > 0.01) in females, and in the distal jejunum, higher crypt cell proliferation (p < 0.01) and a tendency to deeper crypts (p = 0.064) were observed in female pigs as well. In conclusion, lysophospholipids did not increase growth performance in this study; however, the rate of recovery from a poorer starting point was noted, as growth rates recovered and increased faster in the LPL group. In conclusion, unlike the first phase, the LPL group recovered the growth from days 14 to 21 through higher feed intake and weight gain than the CON group. Eventually, the LPL group displayed improved FCR compared with the CON group from days 28 to 42. Further studies are needed to investigate whether this effect continues into the grower–finisher phase.

Lysolecithin might increase ruminal and intestinal emulsification, leading to increased digestibility, but there is minimum information about which is the most appropriate phase to start supplementation and its impacts on feedlot performance and muscle fatty acid profile. Two experiments were conducted to evaluate the effects of phase-feeding of Lysoforte™ eXtend (LYSO). In the first experiment, 1,760 predominantly Bos indicus bullocks (initial body weight of 400 ± 0.561 kg) were allocated in a complete randomized block design. LYSO was supplemented at 1 g/1% of ether extract from the diet. Treatments were no LYSO supplementation (NON); LYSO starting during the growing period and continuing during the finishing period; LYSO starting during the finishing period (FIN); and LYSO during adaptation, growing, and finishing periods (ALL). In the second experiment, the same treatments were evaluated with 96 bullocks (64 Nellore and 32½ Nellore × ½ Angus) in a 4 × 2 factorial arrangement (treatments × genotype). For both studies, intake and average daily gain were accessed; carcass characteristics were evaluated in the first experiment, while digestibility of nutrients and profile of muscle fatty acids were measured in the second experiment. In the first experiment, LYSO increased final body weight (P < 0.022) and average daily gain (GRO and FIN; P < 0.05). In the second study, a treatment × breed × feeding phase interaction was observed with Nellore having a greater average daily gain (P < 0.05) than crossbreds in every feeding phase that LYSO was introduced to the diet. A treatment × feeding phase interaction was observed for digestibility, such that LYSO increased total dry matter (P = 0.004), crude protein (P = 0.043), and NDF (P = 0.001) digestibility during the finishing period. A treatment × breed × day classification was observed (P < 0.05). During the finishing phase, crossbreds treated with LYSO had greater DMI (P < 0.05) on very hot days than NON. Also, animals treated with LYSO presented a greater C18:3 n3 concentration (P = 0.047) in the longissimus. Overall, feeding LYSO during GRO and FIN enhanced feedlot performance and should lead to higher intakes during very hot days of the finishing feeding period.

IntroductionThe mechanism of the immediate adverse drug reactions (ADRs) induced by ShenMai injection (SMI) has not been completely elucidated. Within 30 minutes, the ears and lungs of mice injected with SMI for the first time showed edema and exudation reactions. These reactions were different from the IV hypersensitivity. The theory of pharmacological interaction with immune receptor (p-i) offered a new insight into the mechanisms of immediate ADRs induced by SMI.MethodsIn this study, we determined that the ADRs were mediated by thymus-derived T cells through the different reactions of BALB/c mice (thymus-derived T cell normal) and BALB/c nude mice (thymus-derived T cell deficient) after injecting SMI. The flow cytometric analysis, cytokine bead array (CBA) assay and untargeted metabolomics were used to explain the mechanisms of the immediate ADRs. Moreover, the activation of the RhoA/ROCK signaling pathway was detected by western blot analysis.ResultsIn BALB/c mice, the vascular leakage and histopathology results showed the occurrence of the immediate ADRs induced by SMI. The flow cytometric analysis revealed that CD4+ T cell subsets (Th1/Th2, Th17/Treg) were imbalanced. And the levels of cytokines such as IL-2, IL-4, IL12P70 and INF-γ increased significantly. However, in BALB/c nude mice, all the indicators mentioned above have not changed significantly. The metabolic profile of both BALB/c mice and BALB/c nude mice was significantly changed after injecting SMI, and the notable increase in lysolecithin level might have a greater association with the immediate ADRs induced by SMI. The Spearman correlation analysis revealed that LysoPC (18:3(6Z,9Z,12Z)/0:0) showed a significant positive correlation with cytokines. After injecting SMI, the levels of RhoA/ROCK signaling pathway-related protein increased significantly in BALB/c mice. Protein-protein interaction (PPI) showed that the increased lysolecithin levels might be related to the activation of the RhoA/ROCK signaling pathway.DiscussionTogether, the results of our study revealed that the immediate ADRs induced by SMI were mediated by thymus-derived T cells, and elucidated the mechanisms of such ADRs. This study provided new insights into the underlying mechanism of immediate ADRs induced by SMI.

Simple Summary: The exogenous enzymes and emulsifiers have the potential to produce more energy from fat and improve its utilization and absorption by poultry birds. Therefore, the main goal of this study is to investigate the effects of ditary supplementation of lipase and lysolecithin on growth performance, nutrient digestibility, and meat quality parameters of broilers chicken fed low energy diet. From our findings, the supplementing 0.08% lipase and lysolecithin with a low-energy diet could exhibit better growth performance and meat quality of broilers. Moreover, lipase and lysolecithin alleviate the negative effect of low energy in broilers This study aimed to investigate the effect of dietary lysolecithin (LYSO) and lipase supplementation on productive performance, nutrient retention, and meat quality of broiler chicken fed a low energy diet. For this purpose, a total of 360 chicks were randomly alienated into six treatments, having six replicates (no = 10) birds each replicate. The dietary treatments were followed as control (CON fed as normal energy diet), LE (CON—100 kcal/kg from BD. basal diet), LIP 0.04 (LE + 0.04% lipase), LYSO 0.04 (LE + 0.04% lysolecithin), LIP + LYSO 0.04 (LE + 0.04% lipase and lysolecithin), and LIP + LYSO 0.08 (LE. + 0.08% lipase and lysolecithin). The birds fed with LIP + LYSO 0.04 exhibited higher weight gain than LYSO 0.08 and CON (p < 0.05), and higher feed intake (F.I.) was also observed in LIP + LYSO 0.04 than CON. However, lipase and emulsifier dietary effects were non-significant on FCR. (p > 0.05). Effects of experimental diets on dry matter (DM), crude protein (CP), and fat digestibility were also non-significant (p > 0.05). Similarly, the blood biochemical profile (total cholesterol, triglycerides, LDL, HDL) of the broiler showed no significant difference (p > 0.05) by dietary treatments. Similarly, liver enzymes, AST and A.L.T., were also not statistically significant (p > 0.05) among all dietary treatments. Similarly, supplementation of LIP and LYSO had a non-significant (p > 0.05) effect on breast meat fatty acids composition. Conclusively, adding LIP + LYSO 0.08 to a low energy diet could demonstrate better growth performance and reduce the negative impact of a low-energy diet. [ABSTRACT FROM AUTHOR]

Simple Summary: Lysolecithin derived from hydrolysis of soy lecithin has been widely used as emulsifier in the feed industry to improve growth performance of farm animals for some time. The components of Lysolecithin have proved to have multiple functions, but the real mechanism of action of Lysolecithin on growth promotion in the animal is still unclear. To investigate how it works, we executed this trial. The results show that, besides improving growth performance of broilers, supplementation of Lysolecithin also improved ileal digestibility of amino acids. Further studies found that nutrient (amino acids and fatty acids) transporter genes in the small intestine and growth-related genes in the liver and muscle of broilers were significantly upregulated by supplementation of Lysolecithin independent of experimental diet nutrition level. Upregulating the nutrient transporter gene and growth-related gene expression of the host might be the action mechanism of lysolecithin on growth promotion in animals. By understanding its mechanism of action, researchers can develop new feed additives with better function and lower cost to promote the growth of farm animals and meet the ever-growing need for animal protein in the future. We investigated the effect and interaction of lysolecithin (LPL) and nutrition level on growth performance, nutrient ileal digestibility, expression of growth-related genes and nutrient transporter genes in broilers. A total of 1280 one day old Ross 308 mixed sex chicks with an average body weight 42.23 ± 2.4 g were randomly allotted into 2 × 2 factorial arrangement (20 replicates per treatment and 16 chickens per replicate) with two types of diet (Normal nutrition treatments starter, grower and finisher diets with ME of 3000 kcal/kg, 3100 kcal/kg and 3200 kcal/kg, respectively, and CP level of 22%, 21%, and 20%, respectively; high nutrition treatments diets with 50 kcal/kg ME and 0.5% CP higher than normal nutrition treatment at each stage). Two levels of LPL supplementation (0 and 500 mg/kg) were also employed. From day 21 to day 35 and full stage of the experiment, the birds fed a high nutrition (HN) diet had a greater body weight gain (BWG) and lower feed conversion ratio (FCR) than those fed a normal nutrition (NN) diet (p < 0.05). Besides, lysolecithin increased BWG significantly (p < 0.05). The birds fed a diet with LPL revealed increasing fat digestibility compared to birds fed the basal diet (p < 0.05). LPL significantly increased the ileal digestibility of amino acids, including Ile, Thr, Phe, His, Arg, Tyr, Glu, Pro, Gly, Ala (p < 0.05). No interaction was found between LPL and nutrition level in BWG, FCR and nutrient digestibility. In HN diet, the genes expression of myogenic differentiation 1 (MYOD1), myogenin (MYOG), cluster of differentiation 36 (CD36), fatty acid-binding protein (FABP1), cationic amino acid transporter 1 (CAT1) and Y + L amino acid transporter 1 (y+, LAT1) were significantly elevated via LPL supplementation (p < 0.05). In NN diet, LPL significantly increased the genes expression of growth hormone (GH), insulin-like growth factor 1 (IGF1), MYOD1 and y+, LAT1 (p < 0.05). In conclusion, upregulating the nutrients transporter gene and growth-related gene expression of the host, independent of nutrition level changes, may be the action mechanism of lysolecithin on growth promotion in animals. [ABSTRACT FROM AUTHOR]

High salt (HS) intake induces hypertension and cognitive impairment. Preventive strategies include against dietary supplements. Soybean lecithin is a widely used phospholipid supplement. Lysolecithin is important in cell signaling, digestion, and absorption. This study aimed to investigate the effects of lysophosphatidylcholine containing >70% of the total phospholipids (LPC70), on hypertension and cognitive impairment induced in mice by HS intake. Mice were provided with HS solution (2% NaCl in drinking water) with or without LPC70 for 12 weeks. Blood pressure, cognitive function, and inflammatory response of intestine were determined. Hypertension and impaired object recognition memory induced by HS intake were implicated with increased inducible nitric oxide synthase in the small intestine and tau hyperphosphorylation in the prefrontal cortex. LPC70 treatment prevented cognitive impairment by suppressing inducible nitric oxide synthase and tau hyperphosphorylation. LPC70 may be valuable as a functional food component in preventing HS-induced cognitive impairment. • HS intake induces hypertension and increases iNOS expression in the small intestine of mice. • HS intake impairs object recognition memory, potentially associated with tau hyperphosphorylation. • LPC70 prevents the adverse effects induced by HS intake in mice. [ABSTRACT FROM AUTHOR]

A 70-day feeding trial was conducted to investigate effects of dietary lysolecithin on growth performance, serum biochemical indexes, antioxidant capacity, lipid metabolism and inflammation-related genes expression of juvenile large yellow croaker (Larimichthys crocea) with initial weight of 6.04 ± 0.08 g. A formulated diet containing approximately 42% crude protein and 12.5% crude lipid was used as the control diet (CON). The other three experimental diets were formulated with supplementation of 0.2%, 0.4% and 0.6% lysolecithin based on the control diet, respectively. Results showed that weight gain rate (WGR) and specific growth rate (SGR) significantly increased in fish fed diets with lysolecithin compared with those in the control diet (P < 0.05). Fish fed diets with 0.4% and 0.6% lysolecithin had notably higher lipid content in muscle than that in the control diet (P < 0.05). When fish were fed diets with lysolecithin, serum high-density lipoprotein cholesterol (HDL-c) content was notably higher than that in the control diet (P < 0.05), while fish fed the diet with 0.6% lysolecithin had a significant lower serum low-density lipoprotein cholesterol (LDL-c) content than that in the control diet (P < 0.05). Meanwhile, serum aspartate transaminase (AST) and alanine transaminase (ALT) activities in fish fed diets with lysolecithin were remarkably lower than those in the control diet (P < 0.05). With the increase of dietary lysolecithin from 0.2% to 0.6%, mRNA expression of stearoyl-coenzyme A desaturase 1 (scd1), diacylglycerol acyltransferase 2 (dgat2) and sterol-regulatory element binding protein 1 (srebp1) showed decreasing trends. Furthermore, mRNA expression of carnitine palmitoyl transferase 1 (cpt1) and lipoprotein lipase (lpl) among each dietary lysolecithin treatment were significantly higher than those in the control diet (P < 0.05). In terms of inflammation, mRNA expression of tumor necrosis factor α (tnf-α) and interleukin-1 β (il-1β) were significantly down-regulated in fish fed diets with lysolecithin compared with those in the control diet (P < 0.05), while the mRNA expression of interleukin-10 (il-10) was significantly higher than that in the control diet (P < 0.05). In conclusion, dietary lysolecithin could promote the growth performance, improve hepatic lipid metabolism and regulate inflammation response in juvenile large yellow croaker, and the optimal supplement level of lysolecithin was approximately 0.4% in this study. • Dietary lysolecithin could significantly improve growth performance of juvenile large yellow croaker. • Diets supplemented with lysolecithin could enhance lipid metabolism and alleviate fat accumulation in liver. • Lysolecithin could exert beneficial effects on antioxidant capacity and inflammation response to improve health status. [ABSTRACT FROM AUTHOR]

Porphyromonas gingivalis is a notorious keystone periodontal pathogen. However, it is difficult to selectively inhibit its growth in the oral cavity. Thereby, liposome-based antibacterial agents were investigated to suppress the growth of P. gingivalis. The antibacterial activities of enzymatically prepared lysolecithin-fatty acid liposomes (Lyso-FAL) were comparable to those of free-form linoleic acid in a simple aqueous system with a minimum inhibitory concentration (MIC) of 4.8 μg/mL. However, this value was 2.8-fold lower than those of the lecithin liposomes including the same amount of free fatty acids (e.g., linoleic acid). This indicated that the lysolecithin liposomes are very efficient in the delivery of free fatty acids from the aqueous medium to P. gingivalis. Remarkably, the antibacterial activities in the presence of milk and milk alternatives were significantly stronger (MIC, 35 μg/mL) than free-form linoleic acid (MIC, ≥100 μg/mL). The higher antibacterial activities of the liposomal fatty acids might be due to the efficient delivery of the antibacterial fatty acids from the liposomes to P. gingivalis even in the presence of emulsified fat globules and protein micelles in milk and milk substitutes. Besides, the lysolecithin-free fatty acid liposomes hardly inhibited the growth of Gram (+) bacteria including the oral probiotics (e.g., Limosilactobacillus reuteri). Overall, we envisage that the lysolecithin liposomes may serve as an excellent nano-scale delivery system of multi-functional free fatty acids to targets in complex food systems. [Display omitted] • Lysolecithin liposomes encapsulating linoleic and oleic acids are comparable to soy lecithin liposomes in terms of liposome morphology and emulsifying activities. • Liposomal fatty acids inhibit Porphyromonas gingivalis growth more efficiently than free fatty acids in the presence of milk and milk alternatives. • The lysolecithin liposomes could be used as nano-carrier of fatty acids to P. gingivalis. [ABSTRACT FROM AUTHOR]

Background and purpose: Piperine as the main alkaloid of black pepper has antioxidant and neuroprotective properties, so, it is an appropriate candidate to be studied in animal models of multiple sclerosis. This research aimed at investigating the effect of pretreatment with piperine on spatial memory, oxidative stress, and myelin repair gene markers in local demyelination model. Materials and methods: Adult male Wistar rats (200–220 g) were studied in four experimental groups (n=8 per group). Demyelination was induced by bilateral injection of lysolecithin (LPC) into the CA1 region of the hippocampus. Piperine was injected intraperitoneally at 5 mg/kg for two weeks before induction of demyelination until the end of the experiment. The effect of piperine on spatial memory was assessed by Morris water maze. The gene expression analysis on iNOS, Nrf2, HO1, and MBP was done using qPCR. Total antioxidant capacity in the hippocampal tissue was measured by FRAP biochemical assay. Results: Pretreatment with piperine significantly reduced escape latency and swimming distance and increased time spent in target quadrant in Morris water maze test (P

The aim of this study to evaluate the effect of β-mannanase. Lysolecithin and Probiotic on some reproductive performance and hormone profile in female quail. Six hundred one day - old quail birds were randomly divided to four treatments (60 birds/treatment) with 3 replicates for each group treatment (20 birds / replicate) and at three duration periods. The first period 1-7 weeks, second period 7 - 13 weeks, third period 1-13 weeks. The group of study were control was fed on a standard ration. the second, third and fourth treatments were given β-mannanase. Lysolecithin. probiotic 0.5 g /kg ration respectively. Blood samples wear taken for blood serum analysis. including estimation of follicle- stimulating hormone and luteinizing hormone. The results revealed that the treated groups showed a significant increase in relative weight of the ovary and oviduct compared with control group. β-mannanase and probiotic groups showed a significant increase in the oviduct length compared with the control and Lysolecithin groups. There was a significant increase in the numbers of growing and mature follicles and weight of large follicle in all treated groups compared with control group. The 3rd period showed a significant increase in the relative weight of ovary. oviduct and numbers of growing follicles. while the 2nd and 3rd period showed a significant increase in the oviduct length. About the interaction between treatments and periods. the best result appeared in the ovarian relative weight in the 3rd period for probiotic and β-mannanase. the 3rd period of probiotic showed a significant increase in the oviduct relative weight and for the oviduct length at 2ed and 3rd period for probiotic and β-mannanase. while 3rd period of probiotic show best interaction in the numbers of growing follicles, as 2nd and 3rd periods showed better increase in the mature follicle's numbers and for large follicle weight in 1st and 2nd period of probiotic. The result also showed a significant increase in the FSH and LH level in all treated groups compared with control group. The 2nd and 3rd period were better significantly in the level of FSH and LH. Probiotic at 2nd and 3rd period showed a significant interaction on the level of FSH. On the other hand, 2nd and 3rd period for the β-mannanase and probiotic showed a better significant in the LH level. In conclusion. β-mannanase. Lysolecithin and probiotic supplementation to quail ration improved the hormonal status and enhance reproduction.

This study aimed to investigate the effect of dietary lysolecithin (LYSO) and lipase supplementation on productive performance, nutrient retention, and meat quality of broiler chicken fed a low energy diet. For this purpose, a total of 360 chicks were randomly alienated into six treatments, having six replicates (no = 10) birds each replicate. The dietary treatments were followed as control (CON fed as normal energy diet), LE (CON—100 kcal/kg from BD. basal diet), LIP 0.04 (LE + 0.04% lipase), LYSO 0.04 (LE + 0.04% lysolecithin), LIP + LYSO 0.04 (LE + 0.04% lipase and lysolecithin), and LIP + LYSO 0.08 (LE. + 0.08% lipase and lysolecithin). The birds fed with LIP + LYSO 0.04 exhibited higher weight gain than LYSO 0.08 and CON (p < 0.05), and higher feed intake (F.I.) was also observed in LIP + LYSO 0.04 than CON. However, lipase and emulsifier dietary effects were non-significant on FCR. (p > 0.05). Effects of experimental diets on dry matter (DM), crude protein (CP), and fat digestibility were also non-significant (p > 0.05). Similarly, the blood biochemical profile (total cholesterol, triglycerides, LDL, HDL) of the broiler showed no significant difference (p > 0.05) by dietary treatments. Similarly, liver enzymes, AST and A.L.T., were also not statistically significant (p > 0.05) among all dietary treatments. Similarly, supplementation of LIP and LYSO had a non-significant (p > 0.05) effect on breast meat fatty acids composition. Conclusively, adding LIP + LYSO 0.08 to a low energy diet could demonstrate better growth performance and reduce the negative impact of a low-energy diet.

We investigated the effect and interaction of lysolecithin (LPL) and nutrition level on growth performance, nutrient ileal digestibility, expression of growth-related genes and nutrient transporter genes in broilers. A total of 1280 one day old Ross 308 mixed sex chicks with an average body weight 42.23 ± 2.4 g were randomly allotted into 2 × 2 factorial arrangement (20 replicates per treatment and 16 chickens per replicate) with two types of diet (Normal nutrition treatments starter, grower and finisher diets with ME of 3000 kcal/kg, 3100 kcal/kg and 3200 kcal/kg, respectively, and CP level of 22%, 21%, and 20%, respectively; high nutrition treatments diets with 50 kcal/kg ME and 0.5% CP higher than normal nutrition treatment at each stage). Two levels of LPL supplementation (0 and 500 mg/kg) were also employed. From day 21 to day 35 and full stage of the experiment, the birds fed a high nutrition (HN) diet had a greater body weight gain (BWG) and lower feed conversion ratio (FCR) than those fed a normal nutrition (NN) diet (p < 0.05). Besides, lysolecithin increased BWG significantly (p < 0.05). The birds fed a diet with LPL revealed increasing fat digestibility compared to birds fed the basal diet (p < 0.05). LPL significantly increased the ileal digestibility of amino acids, including Ile, Thr, Phe, His, Arg, Tyr, Glu, Pro, Gly, Ala (p < 0.05). No interaction was found between LPL and nutrition level in BWG, FCR and nutrient digestibility. In HN diet, the genes expression of myogenic differentiation 1 (MYOD1), myogenin (MYOG), cluster of differentiation 36 (CD36), fatty acid-binding protein (FABP1), cationic amino acid transporter 1 (CAT1) and Y + L amino acid transporter 1 (y+, LAT1) were significantly elevated via LPL supplementation (p < 0.05). In NN diet, LPL significantly increased the genes expression of growth hormone (GH), insulin-like growth factor 1 (IGF1), MYOD1 and y+, LAT1 (p < 0.05). In conclusion, upregulating the nutrients transporter gene and growth-related gene expression of the host, independent of nutrition level changes, may be the action mechanism of lysolecithin on growth promotion in animals.

ABSTRACT: Lysolecithin is used as a feed additive to aid fat digestion and absorption in broiler chickens. Previous research has shown that dietary fat source influences how broilers respond to lysolecithin supplementation. Therefore, the objective of this study was to investigate the effect of lysolecithin on a diet formulated with soybean oil on jejunum morphology and expression of selected genes in broiler chickens. Male Cobb 500 chickens were fed a Control diet or the Control diet supplemented with lysolecithin (TRT) from day of hatch to day 28. Jejunal samples were collected at day 10 for morphological and gene expression analysis. Feeding the TRT diet did not affect BW, villus height (VH), crypt depth (CD) or VH/CD ratio compared to Control fed chickens. Differential gene expression in the jejunum was analyzed using a custom microarray. Using a t test, 36 genes were found to be upregulated in TRT fed chickens compared to chickens fed the Control diet. The two most upregulated genes were carbonic anhydrase VII and interleukin 8-like 2, which are associated with healthy intestines. In summary, lysolecithin supplementation in a diet formulated with soybean oil caused no morphological changes but upregulated a number of genes in the jejunum.

Adel Galeshi,1,2 Maryam Ghasemi-Kasman,3,4 Farideh Feizi,2,3 Nahid Davoodian,5,6 Leila Zare,7 Zeinab Abedian3 1Babol University of Medical Sciences, Babol, Iran; 2Department of Anatomical Sciences, Faculty of Medicine, Babol University of Medical Sciences, Babol, Iran; 3Cellular and Molecular Biology Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran; 4Neuroscience Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran; 5Molecular Medicine Research Center, Hormozgan Health Institute, Hormozgan University of Medical Sciences, Bandar Abbas, Iran; 6Department of Clinical Biochemistry, Faculty of Medicine, Hormozgan University of Medical Sciences, Bandar Abbas, Iran; 7Department of Physiology, School of Medical Sciences, Tarbiat Modares University, Tehran, IranCorrespondence: Maryam Ghasemi-KasmanHealth Research Institute, Babol University of Medical Sciences, PO Box 4136747176, Babol, IranTel +98 113 219 0557Fax +98 113 219 0557Email m.ghasemi@mubabol.ac.irFarideh FeiziDepartment of Anatomical Sciences, Faculty of Medicine, Babol University of Medical Sciences, PO Box 4136747176, Babol, IranTel +98 113 219 2033Fax +98 113 219 9936Email faridehfeizi@yahoo.comIntroduction: Based on beneficial effects of aspirin and mesenchymal stem cells (MSCs) on myelin repair, in a preset study, effects of co-administration of aspirin and conditioned medium from adipose tissue-derived stem cells (ADSC-CM) on functional recovery of optic pathway, demyelination levels, and astrocytes’ activation were evaluated in a lysolecithin (LPC)-induced demyelination model of optic chiasm.Methods: LPC (1%, 2 μL) was injected into the rat optic chiasm and animals underwent daily intraperitoneal (i.p.) injections of ADSCs-CM and oral gavage of aspirin at a dose of 25 mg/kg for 14 days post LPC injection. The conductivity of visual signals was assessed using visual evoked potential recordings (VEPs) before LPC injection and on days 7 and 14 post lesion. Immunostaining against PDGFRα as oligodendrocyte precursor cells marker, MOG as mature myelin marker, and GFAP as astrocyte marker was performed on brain sections at day 14 post LPC injection. FluoroMyelin staining was also used to measure the extent of demyelination areas.Results: Our results showed that administration of ADSCs-CM and aspirin significantly reduced the latency of VEP waves in LPC receiving animals. In addition, demyelination levels and GFAP expressing cells were attenuated while the number of oligodendrocyte precursor cells significantly increased in rats treated with ADSCs-CM and aspirin.Conclusion: Overall, our results suggest that co-administration of ADSCs-CM and aspirin improves the functional recovery of optic pathway through amelioration of astrocyte activation and attenuation of demyelination level.Keywords: lysolecithin, demyelination, optic chiasm, mesenchymal stem cells, conditioned medium, aspirin

Multiple sclerosis is an inflammatory disease of the central nervous system (CNS) in which multiple sites of blood-brain barrier (BBB) disruption, focal inflammation, demyelination and tissue destruction are the hallmarks. Here we show that sphingosine-1-phosphate receptor 2 (S1PR2) has a negative role in myelin repair as well as an important role in demyelination by modulating BBB permeability. In lysolecithin-induced demyelination of adult mouse spinal cord, S1PR2 inactivation by either the pharmacological inhibitor JTE-013 or S1PR2 gene knockout led to enhanced myelin repair as determined by higher numbers of differentiated oligodendrocytes and increased numbers of remyelinated axons at the lesion sites. S1PR2 inactivation in lysolecithin-induced demyelination of the optic chiasm, enhanced oligodendrogenesis and improved the behavioral outcome in an optokinetic reflex test. In order to see the effect of S1PR2 inactivation on demyelination, experimental autoimmune encephalitis (EAE) was induced by MOG-peptide. S1PR2 inhibition or knockout decreased the extent of demyelinated areas as well as the clinical disability in this EAE model. Both toxin induced and EAE models showed decreased BBB leakage and reduced numbers of Iba1+ macrophages following S1PR2 inactivation. Our results suggest that S1PR2 activity impairs remyelination and also enhances BBB leakage and demyelination. The former effect could be mediated by Nogo-A, as antagonism of this factor enhances remyelination and S1PR2 can act as a Nogo-A receptor.

The objective of the present study was to evaluate the effects of dietary supplementation of lysolecithin in sows’ diets during the last three weeks of the gestation period and throughout the lactation period on performance and metabolic parameters. In total 60 sows were allocated to two treatments: (a) CG (control group): the sows were fed commercially control diets; (b) LLG (lysolecithin group): the sows were fed the control diets supplemented with 750 g/t of feed supplemented with lysolecithin (Lysoforte Booster DryTM, Kemin Europa N.V., Herentals, Belgium). Backfat was lower in LLG than CG at end of gestation and at weaning (p = 0.030 and 0.044, respectively), while the CG sows mobilized more backfat between day 14 to weaning (p = 0.006). Litter weight at weaning was higher in the LLG (p = 0.027). Fasted glucose levels at day 14 of lactation tended to be lower in LLG compared to CG (p = 0.074). Urea concentrations were higher in LLG than CG at day 14 (p = 0.002). Lysolecithin supplemented sows compared to the control mobilized less tissue during lactation to support lactation demands. In conclusion, lysolecithin supplementation in sows resulted in improved litter weight at weaning without an excessive catabolism of backfat tissue, most probably due to an efficient nutrient utilization, which warrants further investigation.

A better molecular understanding of the temperature-triggered drug release from lysolipid-based thermosensitive liposomes (LTSLs) is needed to overcome the recent setbacks in developing this important drug delivery system. Enhanced drug release was previously rationalized in terms of detergent-like effects of the lysolipid monostearyl lysophosphatidylcholine (MSPC), stabilizing local membrane defects upon LTSL lipid melting. This is highly surprising and here referred to as the 'lysolipid paradox,' because detergents usually induce the opposite effect─they cause leakage upon freezing, not melting. Here, we aim at better answers to (i) why lysolipid does not compromise drug retention upon storage of LTSLs in the gel phase, (ii) how lysolipids can enhance drug release from LTSLs upon lipid melting, and (iii) why LTSLs typically anneal after some time so that not all drug gets released. To this end, we studied the phase transitions of mixtures of dipalmitoylphosphatidylcholine (DPPC) and MSPC by a combination of differential scanning and pressure perturbation calorimetry and identified the phase structures with small- and wide-angle X-ray scattering (SAXS and WAXS). The key result is that LTSLs, which contain the standard amount of 10 mol % MSPC, are at a eutectic point when they release their cargo upon melting at about 41 °C. The eutectic present below 41 °C consists of a MSPC-depleted gel phase as well as small domains of a hydrocarbon chain interdigitated gel phase containing some 30 mol % MSPC. In these interdigitated domains, the lysolipid is stored safely without compromising membrane integrity. At the eutectic temperature, both the MSPC-depleted bilayer and interdigitated MSPC-rich domains melt at once to fluid bilayers, respectively. Intact, fluid membranes tolerate much less MSPC than interdigitated domains─where the latter have melted, the high local MSPC content causes transient pores. These pores allow for fast drug release. However, these pores disappear, and the membrane seals again as the MSPC distributes more evenly over the membrane so that its local concentration decreases below the pore-stabilizing threshold. We provide a pseudobinary phase diagram of the DPPC-MSPC system and structural and volumetric data for the interdigitated phase.

Abstract Introduction Several experimental studies have suggested the potential remyelinating effects of vitamin D (VitD) supplements regardless of the presence of VitD deficiency. This study aims to analyze neurogenesis in a model of toxic demyelination in order to evaluate the effects of VitD on demyelination and remyelination. Material and methods We used 24 male Wistar rats that had received surgical lesions to the corpus callosum and were injected with lysolecithin. Rats were divided into three groups: Group 1 included eight rats with lesions to the corpus callosum but not lysolecithin injections (sham group), group 2 included eight rats with lesions to the corpus callosum that were injected with lysolecithin (lysolecithin group), and group 3 included eight rats with lesions that were injected with lysolecithin and received VitD (VitD group). We analyzed neurogenesis both in the subventricular zone and at the lesion site. Results Administration of VitD promotes the proliferation and differentiation of neural stem cells in the subventricular zone and the migration of these cells to the lesion site in the corpus callosum; these cells subsequently differentiate into oligodendrocyte lineage cells and produce myelin basic protein. This phenomenon was not caused by microglial activation, which was less marked in rats receiving VitD. Megalin expression did not increase at the lesion site, which suggests that VitD is internalized by other mechanisms. Conclusion Our results support the hypothesis that regardless of the presence of VitD deficiency, treatment with VitD may contribute to remyelination by promoting the proliferation of oligodendrocyte precursor cells.

This study aimed to evaluate the effects of dietary supplementation of lysolecithin emulsifier on growth performance, nutrient digestibility, and blood lipid profiles in growing broiler chickens. In total, 1,020 1-day-old male Ross 308 broiler chickens with an average initial live weight of 43±1.2 g were randomly allotted to five dietary treatments for a 35 d experiment. The treatments included: (1) NC, negative control (metabolizable energy (ME)=3,100 kcal/kg for phase 1 and phase 2), (2) PC, positive control (ME=3,200 kcal/kg), (3) T1, NC+0.03% lysolecithin, (4) T2, NC+0.06% lysolecithin, and (5) T3, NC+0.09% lysolecithin. During days 1–35, the feed conversion ratios (FCR) of broiler chickens fed with T2 and T3 diets were lower than those of broiler chickens fed with NC diet (P

Abstract Proteoglycans are promising therapeutic targets in Multiple Sclerosis (MS), because they regulate many aspects of the immune response. This was studied using surfen, an agent that binds both heparan sulphate proteoglycans (HSPGs) and chondroitin sulphate proteoglycans (CSPGs). Initial cell culture work on bone marrow derived macrophages (BMDMs) found that surfen reduced concentrations of the chemokines CCL2, CCL4 and CCL5, with reduced messenger (m)RNA expression for Tumor Necrosis Factor, IL-6, IL-1β and inducible nitric oxide synthase. These data were further explored using Experimental Autoimmune Encephalomyelitis (EAE) in mice. Surfen reduced clinical signs during EAE when administered from disease onset, and reduced infiltration by CD4 positive T cells and macrophages into the central nervous system. These mice also showed reduced mRNA expression for the chemokines CCL3 and CCL5, with reduced concentrations of CCL2, CCL3 and CCL5. During EAE, surfen treatment induced a persistent increase in Interleukin (IL)-4 concentrations which may enhance T helper 2 responses. During EAE, surfen treatment reduced mRNA expression for HSPGs (NDST1, agrin, syndecan-4, perlecan, serglycin, syndecan-1) and the CSPG versican. By contrast, surfen increased mRNA expression for the CSPG aggrecan, with no effect on neurocan. During EAE, significant positive correlations were found between mRNA expression and clinical score for syndecan-4, serglycin and syndecan-1 and a significant negative correlation for aggrecan. These correlations were absent in surfen treated mice. Repair in the later stages of MS involves remyelination, which was modeled by injecting lysolecithin (lysophosphatidylcholine, LPC) into mouse corpus callosum to create regions of demyelination. When surfen was injected 2 days after LPC, it delayed remyelination of the lesions, but had no effect when injected 7 days after LPC. The delayed remyelination was associated with local increases in CSPG expression. Therefore surfen suppresses inflammation but inhibits remyelination in these models. A mechanism in common may be increased CSPG expression.

• Nano-Hst reduces the latency of VEP waves in lysolecithin-induced demyelination model. • Nano-Hst decreases the levels of activated microglia and reactive astrocytes in focal demyelination model of optic chiasm. • Nano-Hst enhances the endogenous remyelination of optic chiasm in lysolecithin–induced demyelination model. Our recent report demonstrated that hesperetin (Hst) as a citrus flavonoid, significantly reduces the levels of demyelination in optic chiasm of rats. Previous evidence also indicated that nano-hesperetin (nano-Hst) possesses beneficial impacts in experimental models of Alzheimer's disease and autism. In this study, the effects of nano-Hst on latency of visual signals, demyelination levels, glial activation, and expression of Olig2 and MBP were evaluated in lysolecithin (LPC)-induced demyelination model. Focal demyelination was induced by injection of LPC (1%, 2 μL) into the rat optic chiasm. Animals received oral administration of nano-Hst at dose of 20 mg/kg for 14 or 21 days post LPC injection. Visual evoked potential (VEP) recording showed that nano-Hst reduces the latency of visual signals and ameliorates the extent of demyelination areas and glial activation. Expression levels of the Olig2 and MBP were also significantly increased in nano-Hst treated rats. Overall, our data suggest that nano-Hst reduces the latency of visual signals through its protective effects on myelin sheath, amelioration of glial activation, and enhancement of endogenous remyelination. [ABSTRACT FROM AUTHOR]

The aim of this study was to determine the effect of β-mannanase, lysolecithin and probiotics addition to female quail ration in some intestinal histological characteristics and Lactobacillus, E. coli number. Six hundred of one-day-old quail birds were used in this study. The birds were randomly assigned to four treatments with 3 replicates and each replicate 20 birds. In three periods, the first period (1-7) weeks, the second period (7-13 weeks) and the third period (1-13 weeks), the treatments were : control was fed on a standard ration, the second, third and fourth treatment was added to the ration the β-mannanase, Lysolecithin and probiotics 0.5g/kg ration were added, respectively. The results showed a significant improvement (p ≤ 0.05) in the villi length and width compared to control. This was reflected by the significant improvement (p≤0.05) in the villi apparent surface area of the villi. The best results of the mentioned characteristics were recorded in the third and second periods and the best overlap between treatment and period in the treatment of the probiotic at the third and second periods. Both β-mannanase and probiotic treatments significantly (p≤0.05) exceeded the control group in crypt depth and goblet cell percentage, while the third period was significantly exceed (p≤0.05) in the crypt width and depth and the goblet cell percentage and recorded the best overlap of the characteristics mentioned in the probiotic treatment for the third period and the treatment of â-mannanase and probiotic significantly in the intestinal epithelium height on control and lysolecithin group, while the best results for this characteristic were recorded in the third period and was the best overlap in the first period of the probiotics. As for the intestinal content of the microorganisms, probiotics, β-mannanase and lysolecithin groups showed a significant decrease (p≤0.05) in the E. coli number compared with control, a significant increase (p≤0.05) in the Lactobacillus number in probiotic, β-mannanase and lysolecithin groups compared to control, the first period show significant decrease (p≤0.05) in the E.coli number. While the third period showed the best increase in the Lactobacillus number and the first period of the probiotics showed the best overlap between the treatments and periods in E. coli number and showed the third period of the probiotic best overlap for the Lactobacillus. We concluded from this study that β-mannanase, lysolecithin and probiotic addition to female quail an improvement in the intestinal environment represented by some histological characteristics and intestinal content of E. coli and Lactobacillus content. [ABSTRACT FROM AUTHOR]

Background and purpose: Piperine as the main alkaloid of black pepper has antioxidant and neuroprotective properties, so, it is an appropriate candidate to be studied in animal models of multiple sclerosis. This research aimed at investigating the effect of pretreatment with piperine on spatial memory, oxidative stress, and myelin repair gene markers in local demyelination model. Materials and methods: Adult male Wistar rats (200-220 g) were studied in four experimental groups (n=8 per group). Demyelination was induced by bilateral injection of lysolecithin (LPC) into the CA1 region of the hippocampus. Piperine was injected intraperitoneally at 5 mg/kg for two weeks before induction of demyelination until the end of the experiment. The effect of piperine on spatial memory was assessed by Morris water maze. The gene expression analysis on iNOS, Nrf2, HO1, and MBP was done using qPCR. Total antioxidant capacity in the hippocampal tissue was measured by FRAP biochemical assay. Results: Pretreatment with piperine significantly reduced escape latency and swimming distance and increased time spent in target quadrant in Morris water maze test (P<0.0001) . In the Piperine pretreatment group, the expression level of iNOS was significantly lower than that in the LPC group. But the expression levels of Nrf2, Hmox-1 and MBP significantly increased in piperine pretreated group compared to LPC and control groups (P<0.001). Total antioxidant capacity of tissue in piperine pretreated group was more than that in the LPC group and controls (P<0.0001). Conclusion: Piperine improved spatial memory impairment induced by hippocampal demyelination through enhancing antioxidant defense and myelin repair. [ABSTRACT FROM AUTHOR]

1. The potential of lecithin and lysolecithin to improve lipid digestion and growth performance was investigated in three experiments: 1. an in vitro model that mimics the intestinal conditions of the chick, 2. a digestibility trial with chicks (5–7 days of age), and 3. a performance trial until 21 days of age. 2. In experiment 1, palm oil (PO), palm oil with lecithin (PO+L), and palm oil with lysolecithin (PO+LY) were subjected to in vitro hydrolysis and applied to Caco-2 monolayers to assess lipid absorption. 3. The in vitro hydrolysis rate of triglycerides was higher in PO+LY (k = 11.76 × 103/min) than in either PO (k = 9.73 × 103/min) or PO+L (k = 8.41 × 103/min), and the absorption of monoglycerides and free fatty acids was highest (P < 0.01) for PO+LY. In experiment 2, 90 broilers were assigned to three dietary treatments: a basal diet with 4% palm oil, and the basal diet supplemented with either 250 ppm lecithin or lysolecithin. 4. ATTD of crude fat was higher in broilers supplemented with lysolecithin, but was lower in broilers supplemented with lecithin. DM digestibility and AMEn in birds supplemented with lysolecithin were significantly higher (3.03% and 0.47 MJ/kg, respectively). 5. In experiment 3, 480 broilers were randomly allocated to four dietary treatments: basal diet with soybean oil (2%), basal diet with lecithin (2%), soybean oil diet with 250 ppm lysolecithin, or lecithin oil diet with 250 ppm lysolecithin. 6. Lecithin diets significantly reduced weight at day 10 and 21 compared with soybean oil. However, the addition of lysolecithin to lecithin-containing diets significantly improved bird performance. 7. The results of these studies showed that, in contrast to lecithin, lysolecithin was able to significantly improve the digestibility and energy values of feed in young broilers. [ABSTRACT FROM AUTHOR]

• White matter tracts in the olfactory system respond to lysolecithin administration. • Both demyelinate by 7 days post-injection (dpi) and show remyelination by 30 dpi. • Lateral olfactory tract begins recovery one week earlier than anterior commissure. Demyelination significantly affects brain function. Several experimental methods, each inducing varying levels of myelin and neuronal damage, have been developed to understand the process of myelin loss and to find new therapies to promote remyelination. The present work investigates the effect of one such method, lysolecithin administration, on the white matter tracts in the olfactory system. The olfactory forebrain contains two distinct tracts with differing developmental histories, axonal composition, and function: the lateral olfactory tract (LOT), which carries ipsilateral olfactory information from the olfactory bulb to olfactory cortex, and the anterior commissure (AC), which interconnects olfactory regions across hemispheres. The effects of lysolecithin injections were assessed in two ways: (1) the expression of myelin basic protein, a component of compacted myelin sheaths, was quantified using immunohistochemistry and (2) electron microscopy was used to obtain measurements of myelin thickness of individual axons as well as qualitative descriptions of the extent of damage to myelin and surrounding tissue. Data were collected at 7, 14, 21, and 30 days post-injection (dpi). While both the LOT and AC exhibited significant demyelination at 7 dpi and had returned to control levels by 30 dpi, the process differed between the two tracts. Remyelination occurred more rapidly in the LOT: substantial recovery was observed in the LOT by 14 dpi, but not in the AC until 21 dpi. The findings indicate that (a) the LOT and AC are indeed suitable tracts for studying lysolecithin-induced de- and remyelination and (b) experimental demyelination proceeds differently between the two tracts. [ABSTRACT FROM AUTHOR]

This study investigated the effects of dietary lysolecithin on growth performance, feed utilization and metabolic responses of channel catfish (Ictalurus punctatus). Fish (initial weight: 14.77 ± 0.45 g) were randomly fed one of five practical diets supplemented with graded levels of lysolecithin (0, 125, 250, 375 and 500 mg/kg) in quadruplicate groups for 10 weeks. Results showed that no significant differences in weight gain, condition factor and viscerosomatic index among all the treatments. Fish fed diet supplemented with 250 mg/kg lysolecithin had significantly decreased feed conversion ratio and significantly increased protein efficiency ratio compared to that fed the control diet. The group with 250 mg/kg of dietary lysolecithin had higher protein and lower lipid contents in the whole body, and lower lipid content in the liver than those in the control group. Groups supplemented with 250–500 mg/kg of dietary lysolecithin had significantly higher gastric and intestinal lipase activities than the control group. Dietary lysolecithin at the level of 250 mg/kg significantly increased the activities of Na+, K+‐ATPase, alkaline phosphatase, total antioxidative capacity, total superoxide dismutase, glutathione peroxidase and catalase and significantly decreased the content of malondialdehyde compared to the control diet. In conclusion, dietary supplementation of lysolecithin could confer benefits of feed utilization, body composition and antioxidative capacity of channel catfish. [ABSTRACT FROM AUTHOR]

Development of pharmacotherapies that promote remyelination is a high priority for multiple sclerosis (MS), due to their potential for neuroprotection and restoration of function through repair of demyelinated lesions. A novel preparation of clean-surfaced, faceted gold nanocrystals demonstrated robust remyelinating activity in response to demyelinating agents in both chronic cuprizone and acute lysolecithin rodent animal models. Furthermore, oral delivery of gold nanocrystals improved motor functions of cuprizone-treated mice in both open field and kinematic gait studies. Gold nanocrystal treatment of oligodendrocyte precursor cells in culture resulted in oligodendrocyte maturation and expression of myelin differentiation markers. Additional in vitro data demonstrated that these gold nanocrystals act via a novel energy metabolism pathway involving the enhancement of key indicators of aerobic glycolysis. In response to gold nanocrystals, co-cultured central nervous system cells exhibited elevated levels of the redox coenzyme nicotine adenine dinucleotide (NAD+), elevated total intracellular ATP levels, and elevated extracellular lactate levels, along with upregulation of myelin-synthesis related genes, collectively resulting in functional myelin generation. Based on these preclinical studies, clean-surfaced, faceted gold nanocrystals represent a novel remyelinating therapeutic for multiple sclerosis. [ABSTRACT FROM AUTHOR]

1. This study aimed to quantify the effect of fat type (including unsaturated to saturated ratio (U:S)) and increasing doses of lysolecithin-based products on nutrient availability and growth performance in broiler chickens. 2. A total of 33 separate experimental reports were collated according to predetermined selection criteria to provide 16 performance trials with 'on top' application, and 17 performance trials using reformulated diets, where the contribution of the lysolecithin was taken into account. Data on average daily gain (ADG) and body weight corrected FCR (FCRc) were analysed using the REML method with trial as a random effect. 3. Across the constituent trials, average added dietary fat and oil inclusion was 4.42% (min 1.15%, max 7.00%), with varied U:S ratio (min 0.94, avg 2.50, max 7.65), reflecting diverse fat sources. Overall, neither bird growth performance nor response to lysolecithin supplementation were significantly affected by the U:S ratio of the diets. 4. In performance trials where lysolecithin was added 'on top' of existing formulations, FCRc was significantly reduced by lysolecithin at 250 g/t inclusion compared to the control, with 125 g/t returning an intermediate value. In reformulated trials, FCRc was not significantly affected, suggesting lysolecithin supplementation at 125 and 250 g/t could recover average dietary energy reductions of 57.88 and 73.11 kcal/kg feed, respectively. 5. In conclusion, this study showed that the addition of lysolecithin at levels of 125 g/t and above to broiler diets consistently improved feed efficiency across a range of basal dietary ingredients and fat sources. [ABSTRACT FROM AUTHOR]

Aim: Experimental studies have shown that the progesterone metabolite, allopregnanolone, is endowed with promyelinating effects. The mechanisms underlying these promyelinating effects are not well understood. Therefore, we explored the impact of allopregnanolone's synthetic analogue, ganaxolone, on remyelination and microglial activation following focal demyelination in the corpus callosum of ovariectomized rats. Methods: Ovariectomized adult Sprague Dawley rats received a stereotaxic injection of 2 µL of 1% lysolecithin solution in the corpus callosum followed by daily injections of either ganaxolone (intraperitoneal injection [i.p.], 2.5 mg/kg) or vehicle. The demyelination lesion was assessed 3 and 7 days postdemyelination insult using Luxol fast blue staining and transmission electron microscopy. The expression levels of myelin proteins (MBP, MAG, MOG, CNPase) were explored using Western blot. The inflammatory response and clearance of damaged myelin were evaluated using immunofluorescent staining (Iba1, dMBP, GFAP) and multiplex enzyme‐linked immunosorbent assay (IL‐1β, TNF‐α, IL‐4, IL‐10, IL‐6). Results: Systemic administration of ganaxolone promoted remyelination of lysolecithin‐induced demyelination, upregulated the expression of major myelin proteins, and enhanced microglial clearance of damaged myelin. Astrocytosis, as well as locally produced pro‐ and antiinflammatory cytokines, was not affected by ganaxolone treatment. Conclusion: Ganaxolone promotes remyelination in response to focal demyelination of the corpus callosum of ovariectomized rats. This effect is, at least in part, mediated by enhancing microglial clearance of myelin debris, which creates a conducive environment for a successful remyelination process. [ABSTRACT FROM AUTHOR]

This study aimed to evaluate the effect of supplementing a combination of lysolecithin, synthetic emulsifier, and monoglycerides (LEX) on growth performance, intestinal morphology, and selected carcass traits in broilers fed low-energy diets without added oil. Three hundred one-day-old Arbor Acres (AA) broilers (40.3 ± 3.3 g) were assigned to two dietary treatments with six replicates of 25 birds each and were fed a control low-energy diet without added oil supplemented with 0 and 250 g/t of LEX for 30 days. Growth performance was measured and recorded throughout the study. At slaughter, 60 birds per treatment were used to assess the effect of LEX on the carcass traits. Final average body weight and feed conversion ratio were improved (p < 0.05) in LEX treated birds compared to control. LEX supplementation was linked to higher (p < 0.05) carcass weight and yield and to lower (p < 0.05) abdominal fat and liver weight. Moisture content was higher (p < 0.05) in ground deboned broilers from LEX treatment. Villus height was increased (p < 0.05), and crypt depth reduced (p < 0.05) in the jejunum of birds treated with LEX. This study demonstrates that supplementation of LEX to a low-energy diet without added oil improved performance, carcass weight and yield, reduced abdominal fat deposition, and improved intestinal morphology in broiler chickens.

The impact of different dietary fiber (DF) levels (with or without lysolecithin supplementation) on growth performance, immune response, expression of some lipid regulating genes and intestinal morphology was assessed in 408 Pekin ducks for 2 months. Soybean hulls were added to the diet to provide four different levels of DF: 2.4 (control diet), 3.8, 5.3, and 6.7% for the first four groups, respectively, while groups 5 to 8 fed the same four levels of DF with lysolecithin addition. Increasing dietary DF non-significantly reduced (p > 0.05) the ducks’ body weight (BW). However, ducks fed on 3.8% DF showed higher BW and improved feed conversion ratio. Lysolecithin supplementation with different DF did not support growth performance. Increasing DF with or without lysolecithin had no effect on serum lipid profile (p > 0.05). However, serum high-density lipoproteins (HDL) concentration was significantly increased with increasing fiber level in diet (p ˂ 0.05). Increasing DF with or without lysolecithin addition increased serum antioxidant activities and improved the immune response in terms of phagocytic and lysozyme activities. The DF level reduced the duodenal villi length and mucosal layer thickness while increased the villi width (p ˂ 0.05). Lysolecithin supplementation to diets ameliorated adverse effects on intestinal morphology. Moreover, DF level in ducks’ diet with or without lysolecithin significantly upregulated the expression of fatty acid synthase and lipoprotein lipase (p ˂ 0.05). Thus, it could be concluded that ducks fed on soybean hulls containing a diet at the level of 4.5% and providing 3.8% fiber level with or without lysolecithin showed the best performance.

Background: One of the significant problems in multiple sclerosis (MS) is damage to the visual system, which is the result of demyelination. Studies have suggested a link between central nervous system demyelinating diseases and thyroid disorders, and probably the treatments that increase the level of thyroid hormones are beneficial in multiple sclerosis. Therefore, in this study, the effects of levothyroxine on lysolecithin-induced demyelination/remyelination in rat's optic chiasm were evaluated. Methods: Local demyelination was induced by injection of 2 µl lysolecithin 1% into the rat's optic chiasm. Experimental groups were control, sham, lesion (multiple sclerosis), and lesion-levothyroxine 20, 50 and 100 µg/kg (n = 9). Demyelination/remyelination was evaluated 7, 14 and 21 days after the initiation of treatment. Histomorphological changes were assessed using hematoxylin and eosin staining. Findings: Following the injection of lysolecithin into the optic chiasm, a large demyelination was occurred, which decreased over time, indicating remyelination in this area. Following the treatment with levothyroxine, there was a significant reduction in the amount of demyelination in the treated groups compared to the multiple sclerosis group. This decrease was particularly pronounced at the dose of 100 µg/kg. Conclusion: The results of this study show that injection of lysolecithin in the optic chiasm causes a reversible demyelination. Levothyroxine could produce protective effects against induced demyelination and accelerate remyelination. Therefore, thyroid hormones probably have healing effects in multiple sclerosis, although further studies are needed.

Galectin-1 (Gal-1), a member of a highly conserved family of animal lectins, binds to the common disaccharide [Galβ(1-4)-GlcNAc] on both N- and O-glycans decorating cell surface glycoconjugates. Current evidence supports a role for Gal-1 in the pathophysiology of multiple sclerosis (MS), one of the most prevalent chronic inflammatory diseases. Previous studies showed that Gal-1 exerts neuroprotective effects by promoting microglial deactivation in a model of autoimmune neuroinflammation and induces axonal regeneration in spinal cord injury. Seeking a model that could link demyelination, oligodendrocyte (OLG) responses and microglial activation, here we used a lysolecithin (LPC)-induced demyelination model to evaluate the ability of Gal-1 to preserve myelin without taking part in T-cell modulation. Gal-1 treatment after LPC-induced demyelination promoted a significant decrease in the demyelinated area and fostered more efficient remyelination, concomitantly with an attenuated oligodendroglial progenitor response reflecting less severe myelination damage. These results were accompanied by a decrease in the area of microglial activation with a shift toward an M2-polarized microglial phenotype and diminished astroglial activation. In vitro studies further showed that, mechanistically, Gal-1 targets activated microglia, promoting an increase in their myelin phagocytic capacity and their shift toward an M2 phenotype, and leads to oligodendroglial differentiation. Therefore, this study supports the use of Gal-1 as a potential treatment for demyelinating diseases such as MS.

A double-blind, placebo-controlled, crossover trial was performed to analyze the effects of a small amount of lysolecithin and canola oil on blood glucose levels after consuming japonica rice. Overall, 17 Japanese adult men were assigned to consume 150 g of normally cooked japonica rice (placebo group) and 150 g of japonica rice cooked with 18 mg of lysolecithin and 1.8 g of canola oil (treatment group); these lipids were added as emulsified formulation (EMF) for stability and uniformity. Subsequently, blood samples were collected before and 30, 45, 60, 90, and 120 min after consuming test foods. There was no significant difference in blood glucose, insulin, and triglyceride levels between the groups. However, a stratified analysis of 11 subjects with body mass index (BMI) ≥ 22 revealed that blood glucose levels were significantly lower after 30 min in the treatment group than in the placebo group (p = 0.041). Through in vitro digestibility test, the rice sample of the treatment group was observed to release significantly less glucose within 20 min than that in the placebo group rice. These results suggest that the combination of a small amount of lysolecithin and canola oil modulated the increase in postprandial blood glucose levels induced by the intake of cooked japonica rice in adult men with BMI ≥ 22. This clinical trial was registered with the University Hospital Medical Information Network (UMIN) Center, (UMIN000045744; registered on 15/10/2021).

• FTY720 improves functional recovery of optic pathway in LPC-induced demyelination model of optic chiasm. • FTY720 alleviates demyelination levels and glial activation of optic chiasm following LPC injection. • FTY720 down-regulates the expression levels of HDAC1 and S1PR1 in the optic chiasm. It has been shown that fingolimod (FTY720) possesses beneficial effects on remyelination in the central nervous system (CNS). In this study, the effects of FTY720 and sodium valproate (VPA) as histone deacetylase inhibitor (HDAC) on the conductivity of visual signals, extent of demyelination area, glial activation, and expression levels of HDAC1and S1PR1 have been evaluated in the optic chiasm of lysolecithin (LPC)-induced demyelination model. In order to produce this demyelination model, LPC (1%, 2 μL) was injected into the rat optic chiasm. Latency of visual waves was measured by visual evoked potential (VEP) recording. The extent of demyelination area and level of glial activation were assessed using immunostaining. Gene expression analysis was performed to evaluate the expression levels of HDAC1, S1PR1, Olig2, and MBP in the optic chiasm. Analysis of electrophysiological data showed that LPC administration increased the latency of visual signals. FTY720 improved the functional recovery of the visual pathway and reduced the level of glial activation in the optic chiasm. FTY720 enhanced myelin repair and up-regulated the expression levels of Olig2 and MBP. Additionally, the expression levels of HDAC1 and S1PR1 were significantly reduced in animals treated with FTY720. In contrast to FTY720 treated animals, administration of VPA could not significantly improve the functional recovery of optic pathway following LPC injection. Cumulatively, the results of the present study demonstrate that FTY720 application improves the functional recovery of the optic pathway by reducing demyelination levels, amelioration of glial activation, and down-regulating of S1PR1 and HDAC1. [ABSTRACT FROM AUTHOR]

Abstract Multiple sclerosis is an inflammatory disease of the central nervous system (CNS) in which multiple sites of blood-brain barrier (BBB) disruption, focal inflammation, demyelination and tissue destruction are the hallmarks. Here we show that sphingosine-1-phosphate receptor 2 (S1PR2) has a negative role in myelin repair as well as an important role in demyelination by modulating BBB permeability. In lysolecithin-induced demyelination of adult mouse spinal cord, S1PR2 inactivation by either the pharmacological inhibitor JTE-013 or S1PR2 gene knockout led to enhanced myelin repair as determined by higher numbers of differentiated oligodendrocytes and increased numbers of remyelinated axons at the lesion sites. S1PR2 inactivation in lysolecithin-induced demyelination of the optic chiasm, enhanced oligodendrogenesis and improved the behavioral outcome in an optokinetic reflex test. In order to see the effect of S1PR2 inactivation on demyelination, experimental autoimmune encephalitis (EAE) was induced by MOG-peptide. S1PR2 inhibition or knockout decreased the extent of demyelinated areas as well as the clinical disability in this EAE model. Both toxin induced and EAE models showed decreased BBB leakage and reduced numbers of Iba1+ macrophages following S1PR2 inactivation. Our results suggest that S1PR2 activity impairs remyelination and also enhances BBB leakage and demyelination. The former effect could be mediated by Nogo-A, as antagonism of this factor enhances remyelination and S1PR2 can act as a Nogo-A receptor. Graphical abstract Unlabelled Image Highlights • S1PR2 inactivation decreased fibrinogen extravasation in animal models of MS. • S1PR2 inactivation decreases macrophages in the lesion area. • S1PR2 inactivation increases the number of oligodendrocytes in lesion area. • S1PR2 inactivation enhanced the number of remyelinated axons. • S1PR2 inactivation ameliorate the clinical disability and demyelination in EAE. [ABSTRACT FROM AUTHOR]

Neuroinflammation affects millions of people around the world as a result of injury or stress. Neuroinflammation represents almost all types of neurological diseases such as multiple sclerosis and Alzheimer's disease. Neurodegenerative diseases comprise demyelination and synaptic loss. The inflammatory response is further propagated by the activation of glial cells and modulation of constitutively expressed extracellular matrix proteins. The aim of the present study was to identify the anti-inflammatory effects of purified compounds gallic acid (GA, 1.0 µM) and vanillic acid (VA, 0.2 µM) on the lysolecithin (LPC, 0.003%)-induced model of inflammation. Hippocampal neurons were co-cultured with glial cells, and LPC was added to induce inflammation. Neurite outgrowth was measured by morphometry software. The level of myelination and demyelination was identified by immunostaining and sodium dodecyl sulfate polyacrylamide gel electrophoresis and western blotting techniques using different antibodies. Whole-cell patch clamp recordings were used to observe the sustained repetitive firing pattern. The data showed that GA and VA significantly increased the neurite outgrowth after 48 h in culture. Both compounds significantly reduced the expression of cyclooxygenase-2, NFκB, tenascin-C, chondroitin sulfate proteoglycans and glial fibrillary acidic protein in astrocytes in the LPC-induced model of inflammation. The level of myelin protein in neurites and oligodendrocyte cell bodies was significantly upregulated by GA and VA treatment. The reduction in sustained repetitive firing in the LPC-induced model of inflammation was reversed by both GA and VA treatment. This study supports the hypothesis that VA and GA have anti-inflammatory activities and could be regarded as potential treatments for neurodegenerative disease. [ABSTRACT FROM AUTHOR]

This experiment was conducted to evaluate the effects of emulsifier (Lipidol, active ingredient: lysophospholipids; LPL) and xylanase (200 mg/kg of feed) supplementation in a lower energy diet on performance, nutrient retention, intestinal morphology, blood metabolites and meat quality in broilers. A total of 360 1‐day‐old male chicks (Ross 308) were assigned to five treatments, with six replications of 12 birds each per treatment in a completely randomized design. The five treatments were as follows: (a) higher energy diet (HE); (b) lower energy diet (LE; energy content reduced by 100 kcal/kg compared with the HE); (c) LE + 0.10% LPL (EM); (d) LE + 200 mg xylanase/kg (ENZ); and (e) LE + 0.10% LPL + 200 mg xylanase/kg (EM + ENZ). Broilers fed HE had a higher average daily gain (ADG, day 0–24) and lower average daily feed intake (ADFI) and feed conversion ratio (FCR) from day 11 to 24 and day 0 to 24 than those fed the LE diet. Broilers fed EM or ENZ diets also had lower FCR and ADFI (day 11–24 and day 0–24) than those fed reduced‐energy diets. The inclusion of 0.10% LPL and/or xylanase to the LE diet increased the apparent digestibility of dry matter (DM), nitrogen (N), ether extract (EE) and gross energy (GE), as well as villous height and ratio of villous height to crypt depth in the duodenum and jejunum. Serum free fatty acid (FFA) concentration was lower in birds fed the HE diet, compared with those fed the LE diet. The low‐density lipoprotein cholesterol, total cholesterol and triglyceride concentrations were decreased by LPL supplementation. The relative weight of abdominal fat was higher in birds fed the HE diet, but lower from LPL supplementation. It was concluded that a reduced‐energy diet impaired bird performance, while dietary supplementation of LPL and xylanase to reduced‐energy diets positively affected productive performance, nutrient utilization, intestinal morphology and abdominal fat percentage. [ABSTRACT FROM AUTHOR]

A total of 672 one-d-old Ross 308 (mixed gender) broiler chicks with an average initial body weight of 34.1 ± 0.2 g were used in a 28-d feeding trial to investigate the effect of supplementing low energy diets with an emulsifier or multi-enzyme complex on broiler. Chickens were allocated to one of six treatments with seven pens/treatment and 16 birds/pen. Treatments were (1) PC (basal diet), (2) NC (PC-100 kcal ME/kg), (3) L05 (NC + 0.05% emulsifier), (4) L10 (NC + 0.10% emulsifier), (5) E05 (NC + 0.05% multi-enzyme), and (6) E10 (NC + 0.10% multi-enzyme). Results showed that supplementing low energy diet with 0.10% multi-enzyme or 0.10% emulsifier improved (P < .05) overall body weight gain. The relative weight of breast meat decreased (P < .05) by adding 0.10% multi-enzyme compared to chickens fed E05 diet. Feeding the chickens with E10 diet increased relative weight of abdominal fat. Chickens fed NC or L10 diets had the lowest (P < .05) relative weight of liver. The addition of emulsifier or multi-enzyme to the diets decreased drip loss (P < .05). Results indicated that supplementing low energy diet with multi-enzyme or emulsifier improved growth performance and alleviated negative effects of lowering dietary ME level on meat quality of broilers. [ABSTRACT FROM AUTHOR]

The restricted diffusion-in-a-cone (DC) model is formulated within the context of a slow-motional electron-spin resonance (ESR) line shape to describe the local reorientation of amphiphile molecules in lipid bilayers. A special program is designed to reduce the computation amount, and the computational time for the DC model is comparable to that for the familiar Maier–Saupe (MS) potential model. Special emphasis is placed on comparing the two potential models in ESR line shape calculations. Illustrative analyses of ESR spectra are presented for some selected bilayers. It is found that the DC model is particularly suitable for describing the local dynamic states of single chain systems. The simulation results show that while the two models give similar values for the reorientational rates, the DC model predicts lower local molecular orders. [ABSTRACT FROM AUTHOR]

Multiple sclerosis is characterized by the loss of oligodendrocytes and demyelination of axons. In this study, the effect of caffeine on spatial memory in rats was investigated following demyelination induction by lysolecithin (LPC). The expression of Myelin Basic Protein (MBP), Glial Fibrillary Acidic Protein (GFAP), and Olig2 (oligodendrocyte lineage marker) genes was also assessed in the hippocampus. Animals were divided into seven groups; control group: animals received normal saline by stereotaxic intrahippocampal injection in Dentate Gyrus (DG) area; LPC group: animals received 2 μl lysolecithin by stereotaxic intrahippocampal injection in DG area (they were evaluated 7, 14, and 28 days after LPC injection; Caffeine- treated group: animals were treated with caffeine at doses of 30 mg/kg intraperitoneally for 7, 14, and 28 days after receiving LPC. Behavioral study was performed using Radial Arm Maze. Moreover, the RT- PCR was carried out for gene expression investigation. The demyelination and defective remyelination were noticeable on 28th day which suggests the demyelination decline caused by caffeine. Behavioral study showed that on the post-lesion days, the food finding time in the LPC group was significantly higher than that of the control group. Caffeine consumption significantly attenuated the food finding time in the treatment compared to the LPC group. The RT-PCR analysis indicated that the lysolecithin decreased the MBP expression especially on days 7 and 14 and conversely increased the Olig2 and GFAP expression. In addition, the caffeine enhanced the expression of MBP compared to that of the LPC group and reduced the Olig2 and GFAP expressions. Our results demonstrated that caffeine could increase the remyelination process in hippocampus and improve the spatial memory following demyelination induction by the LPC.